Alexandre Mérieux, Chief Executive Officer, said: "bioMérieux confirmed its strong sales dynamic over the third quarter and continues to enhance its portfolio of innovative solutions for its customers. Given this favorable environment and as announced upon publication of its half-year results, bioMérieux should exceed its annual 8% organic sales growth target."